Processa Pharmaceuticals, Inc. (PCSA)
2.10
+0.16
(+8.25%)
USD |
NASDAQ |
Feb 25, 16:00
2.13
+0.03
(+1.43%)
After-Hours: 20:00
Processa Pharmaceuticals Research and Development Expense (Quarterly) : 1.662M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 50.48M |
| Pyxis Oncology, Inc. | 17.35M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.59M |